The QS regimen is an effective, convenient, and well-tolerated palliative RT approach for advanced HNC, particularly for patients with significant comorbid conditions or poor prognosis. Ongoing studies will clarify the role of QS alongside systemic therapies and advanced technologies.
Crompton et al. (Thu,) studied this question.